Notice of Results, Analyst & Investor Presentation

AI SummaryClose X

N4 Pharma PLC will release its unaudited interim results for the six months ending June 30, 2025, on Thursday, September 25, 2025. An online analyst briefing, hosted by the Chief Executive Officer, will take place at 9:30 am on the same day to review these results. Following the briefing, an investor presentation covering the interim results will be held at 2:00 pm, open to existing and potential shareholders.

Disclaimer*

UK 100

Latest directors dealings